Dong-Chul Han

Papers

Total Citations

H-Index

About

Dong-Chul Han is a pioneer in microfluidic technologies for biomedical applications, with a primary focus on high-throughput screening (HTS) and cytotoxicity testing. His seminal 2004 work, "Serial dilution microchip for cytotoxicity test," which has garnered 40 citations, addresses a critical bottleneck in pharmaceutical development: the need for rapid, miniaturized assays to assess compound safety. Han’s innovation—a microchip capable of generating precise serial dilutions—streamlined the traditionally labor-intensive process of cytotoxicity testing, enabling faster and more reliable evaluation of drug candidates. This contribution directly tackled the challenges posed by the exponential increase in sample numbers from HTS, offering a scalable solution that reduces reagent consumption and enhances throughput. By integrating microfluidics with cell-based assays, Han’s research has laid foundational groundwork for lab-on-a-chip devices in toxicology and drug discovery. His work exemplifies how engineering principles can transform biological analysis, making him a key figure in the evolution of automated, high-efficiency screening platforms.